Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.

Fink AL, Klein SL.

Physiology (Bethesda). 2015 Nov;30(6):408-16. doi: 10.1152/physiol.00035.2015. Review.

PMID:
26525340
2.

Practical review of immunizations in adult patients with cancer.

Ariza-Heredia EJ, Chemaly RF.

Hum Vaccin Immunother. 2015 Nov 2;11(11):2606-14. doi: 10.1080/21645515.2015.1062189. Epub 2015 Jun 25.

PMID:
26110220
3.

Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation.

Li G, Ju J, Weyand CM, Goronzy JJ.

J Immunol. 2015 Aug 1;195(3):865-74. doi: 10.4049/jimmunol.1402389. Epub 2015 Jun 19.

PMID:
26091718
4.

On-label and off-label use of high-dose influenza vaccine in the United States, 2010-2012.

McGrath LJ, Brookhart MA.

Hum Vaccin Immunother. 2015;11(3):537-44. doi: 10.1080/21645515.2015.1011026.

PMID:
25751700
5.

How sex and age affect immune responses, susceptibility to infections, and response to vaccination.

Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B.

Aging Cell. 2015 Jun;14(3):309-21. doi: 10.1111/acel.12326. Epub 2015 Feb 26.

6.

Infection prevention and the medical director: uncharted territory.

Kapoian T, Meyer KB, Johnson DS.

Clin J Am Soc Nephrol. 2015 May 7;10(5):863-74. doi: 10.2215/CJN.06050614. Epub 2015 Feb 20.

7.

Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities.

Nace DA, Lin CJ, Ross TM, Saracco S, Churilla RM, Zimmerman RK.

J Infect Dis. 2015 Jun 15;211(12):1915-24. doi: 10.1093/infdis/jiu622. Epub 2014 Dec 17.

PMID:
25525051
8.

Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults.

Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins TP, Siconolfi B, Meng H, Devine L, Raddassi K, Tsang S, Belshe RB, Hafler DA, Kaech SM, Kleinstein SH, Trentalange M, Allore HG, Shaw AC.

J Infect Dis. 2015 Apr 1;211(7):1174-84. doi: 10.1093/infdis/jiu573. Epub 2014 Nov 2.

PMID:
25367297
9.

Targeted vaccine selection in influenza vaccination.

Wutzler P, Hardt R, Knuf M, Wahle K.

Dtsch Arztebl Int. 2013 Nov 22;110(47):793-8. doi: 10.3238/arztebl.2013.0793. Review.

10.

Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant.

Carroll TD, Matzinger SR, Barry PA, McChesney MB, Fairman J, Miller CJ.

J Infect Dis. 2014 Jan 1;209(1):24-33. doi: 10.1093/infdis/jit540. Epub 2013 Oct 17.

11.

Understanding immunosenescence to improve responses to vaccines.

Goronzy JJ, Weyand CM.

Nat Immunol. 2013 May;14(5):428-36. doi: 10.1038/ni.2588. Epub 2013 Apr 18. Review.

12.

Balancing the Efficacy and Safety of Vaccines in the Elderly.

Amanna IJ.

Open Longev Sci. 2012 Jun 29;6(2012):64-72.

13.

Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study.

Van Ermen A, Hermanson MP, Moran JM, Sweitzer NK, Johnson MR, Vardeny O.

Eur J Heart Fail. 2013 May;15(5):560-4. doi: 10.1093/eurjhf/hfs207. Epub 2013 Jan 4.

14.

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

Couch RB, Patel SM, Wade-Bowers CL, Niño D.

PLoS One. 2012;7(12):e49704. doi: 10.1371/journal.pone.0049704. Epub 2012 Dec 11.

15.

Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity.

Li G, Yu M, Lee WW, Tsang M, Krishnan E, Weyand CM, Goronzy JJ.

Nat Med. 2012 Oct;18(10):1518-24. doi: 10.1038/nm.2963. Epub 2012 Sep 30.

16.

NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.

Pica N, Langlois RA, Krammer F, Margine I, Palese P.

J Virol. 2012 Oct;86(19):10293-301. doi: 10.1128/JVI.01131-12. Epub 2012 Jul 11.

17.

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL; Pandemic H1N1 Vaccine Adult Study Group.

Vaccine. 2012 Jun 13;30(28):4240-8. doi: 10.1016/j.vaccine.2012.04.044. Epub 2012 Apr 23.

18.

Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S.

Aging Dis. 2012 Feb;3(1):68-90. Epub 2011 Sep 30.

19.

Industry meeting demands for more effective vaccines.

Carroll J.

Biotechnol Healthc. 2009 Aug;6(3):37-42.

20.

Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age.

Yu M, Li G, Lee WW, Yuan M, Cui D, Weyand CM, Goronzy JJ.

Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):E879-88. doi: 10.1073/pnas.1109797109. Epub 2012 Mar 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk